Miller Anestesia

231. Hedner U, Erhardtsen E: Potential role for rFVIIa in

transfusion medicine. Transfusion 42:114–124,

2002.

232. Kalicinski P, Kaminski A, Drewniak T, et al: Quick

correction of hemostasis in two patients with fulmi-

nant liver failure undergoing liver transplantation

by recombinant activated factor VII. Transplant

Proc 31:378–379, 1999.

233. Surudo T, Wojcicki M, Milkiewicz P, et al: Rapid

correction of prothrombin time after low-dose

recombinant factor VIIA in patients undergoing

orthotopic liver transplantation. Transplant Proc

35:2323–2325, 2003.

234. rFVIIa OLT Study Group, Lodge JP, Jonas S, Jones

RM, et al: Efficacy and safety of repeated periopera-

tive doses of recombinant factor VIIa in liver trans-

plantation. Liver Transpl 11:973–979, 2005.

235. Planinsic RM, van der Meer J, Testa G, et al: Safety

and efficacy of a single bolus administration of

recombinant factor VIIa in liver transplantation due

to chronic liver disease. Liver Transpl 11:895–900,

2005.

236. Niemann CU, Behrends M, Quan D, et al: Recombi-

nant factor VIIa reduces transfusion requirements

in liver transplant patients with high MELD scores.

Transfus Med 16:93–100, 2006.

237. Mathur VS: The role of the DA1 receptor agonist

fenoldopam in the management of critically ill,

transplant, and hypertensive patients. Rev Cardio-

vasc Med 4(Suppl 1): S35–S40, 2003.

238. Della Rocca G, Pompei L, Costa MG, et al: Fenol-

dopam mesylate and renal function in patients

undergoing liver transplantation: a randomized,

controlled pilot trial. Anesth Analg 99:1604–1609,

2004.

239. Zacharias M, Gilmore IC, Herbison GP, et al: Inter-

ventions for protecting renal function in the perio-

perative period. Cochrane Database Syst Rev

3:CD003590, 2005.

240. Kheterpal S, Tremper KK, Englesbe MJ, et al: Pre-

dictors of postoperative acute renal failure after

noncardiac surgery in patients with previously

normal renal function. Anesthesiology 107:892–

902, 2007.

241. Schroeder RA, Collins BH, Tuttle-Newhall E, et al:

Intraoperative fluid management during orthotopic

liver transplantation. J Cardiothorac Vasc Anesth

18:438–441, 2004.

242. Massicotte L, Lenis S, Thibeault L, et al: Effect of low

central venous pressure and phlebotomy on blood

product transfusion requirements during liver

transplantations. Liver Transpl 12:117–123, 2006.

243. Shaw BW Jr, Martin DJ, Marquez JM, et al: Venous

bypass in clinical liver transplantation. Ann Surg

200:524–534, 1984.

244. Tisone G, Mercadante E, Dauri M, et al: Surgical

versus percutaneous technique for veno-venous

bypass during orthotopic liver transplantation: A

prospective randomized study. Transplant Proc

31:3162–3163, 1999.

245. Sakai T, Planinsic RM, Hilmi IA, Marsh JW: Com-

plications associated with percutaneous placement

of venous return cannula for venoveno bypass in

adult orthotopic liver transplantation. Liver Transpl

13:961–965, 2007.

246. Hosein Shokouh-Amiri M, Osama Gaber A, Bagous

WA, et al: Choice of surgical technique influences

perioperative outcomes in liver transplantation.

Ann Surg 231:814–823, 2000.

247. Chari RS, Gan TJ, Robertson KM, et al: Venovenous

bypass in adult orthotopic liver transplantation:

Routine or selective use? J Am Coll Surg 186:683–

690, 1998.

248. Rossi G, Langer M, Maggi U, et al: Veno-venous

bypass versus no bypass in orthotopic liver trans-

plantation: Hemodynamic, metabolic, and renal

data. Transplant Proc 30:1871–1873, 1998.

249. Schwarz B, Pomaroli A, Hoermann C, et al: Liver

transplantation without venovenous bypass: Morbi-

dity and mortality in patients with greater than 50%

reduction in cardiac output after vena cava clam-

ping. J Cardiothorac Vasc Anesth 15:460–462, 2001.

250. Parrilla P, Sanchez-Bueno F, Figueras J, et al: Analy-

sis of the complications of the piggy-back technique

in 1,112 liver transplants. Transplantation 67:1214–

1217, 1999.

251. Webster NR, Bellamy MC, Lodge JP, et al: Haemody-

namics of liver reperfusion: Comparison of two anaes-

thetic techniques. Br J Anaesth 72:418–421, 1994.

252. Koelzow H, Gedney JA, Baumann J, et al: The effect

of methylene blue on the hemodynamic changes

during ischemia reperfusion injury in orthotopic liver

transplantation. Anesth Analg 94:824–829, 2002.

253. Ayanoglu HO, Ulukaya S, Tokat Y: Causes of postre-

perfusion syndrome in living or cadaveric donor

liver transplantations. Transplant Proc 35:1442–

1444, 2003.

254. Acosta F, Sansano T, Contreras RF, et al: Changes in

serum potassium during reperfusion in liver trans-

plantation. Transplant Proc 31:2382–2383, 1999.

255. Nanashima A, Pillay P, Crawford M, et al: Analysis

of postrevascularization syndrome after orthotopic

liver transplantation: The experience of an Austra-

lian liver transplantation center. J Hepatobil Pan-

creat Surg 8:557–563, 2001.

256. Acosta F, Rodriguez MA, Sansano T, et al: Influence

of surgical technique on postreperfusion syndrome

during liver transplantation. Transplant Proc

31:2380–2381, 1999.

257. Aggarwal S, Kang Y, Freeman JA, et al: Postreperfu-

sion syndrome: Hypotension after reperfusion of

the transplanted liver. J Crit Care 8:154–160, 1993.

258. Markmann JF, Markmann JW, Desai NM, et al: Ope-

rative parameters that predict the outcomes of

hepatic transplantation. J Am Coll Surg 196:566–

572, 2003.

259. Mandell MS, Lockrem J, Kelley SD: Immediate tra-

cheal extubation after liver transplantation: Expe-

rience of two transplant centers. Anesth Analg

84:249–253, 1997.

260. Glanemann M, Langrehr J, Kaisers U, et al: Postope-

rative tracheal extubation after orthotopic liver

transplantation. Acta Anaesthesiol Scand 45:333–

339, 2001.

261. Neelakanta G, Sopher M, Chan S, et al: Early tra-

cheal extubation after liver transplantation. J Car-

diothorac Vasc Anesth 11:165–167, 1997.

262. Findlay JY, Jankowski CJ, Vasdev GM, et al: Fast

track anesthesia for liver transplantation reduces

postoperative ventilation time but not intensive care

unit stay. Liver Transpl 8:670–675, 2002.

263. Mandell MS, Lezotte D, Kam I, et al: Reduced use of

intensive care after liver transplantation: Patient

attributes that determine early transfer to surgical

wards. Liver Transpl 8:682–687, 2002.

264. Biancofiore G, Romanelli AM, Bindi ML, et al: Very

early tracheal extubation without predetermined

criteria in a liver transplant recipient population.

Liver Transpl 7:777–782, 2001.

265. Mandell MS, Lezotte D, Kam I, et al: Reduced use of

intensive care after liver transplantation: Influence

of early extubation. Liver Transpl 8:676–681, 2002.

266. Mandell MS, Stoner TJ, Barnett R, et al: Amulticenter

evaluation of safety of early extubation in liver trans-

plant recipients. Liver Transpl 13:1557–1563, 2007.

267. Moretti EW, Robertson KM, Tuttle-Newhall JE, et

al: Orthotopic liver transplant patients require less

postoperative morphine than do patients under-

going hepatic resection. J Clin Anesth 14:416–420,

2002.

268. Donovan KL, Janicki PK, Striepe VI, et al: Decreased

patient analgesic requirements after liver transplan-

tation and associated neuropeptide levels. Trans-

plantation 63:1423–1429, 1997.

269. Eisenach JC, Plevak DJ, Van Dyke RA, et al: Com-

parison of analgesic requirements after liver trans-

plantation and cholecystectomy. Mayo Clin Proc

64:356–359, 1989.

270. Kato T, Ruiz P, Thompson JF, et al: Intestinal and

multivisceral transplantation. World J Surg 26:226–

237, 2002.

271. Bellamy MC, Enright SM, Young Y, et al: Living

related small bowel transplantation: Anaesthesia

and peri-operative care. Eur J Anaesthesiol 14:450–

454, 1997.

272. Singh N: The current management of infectious

diseases in the liver transplant recipient. Clin Liver

Dis 4:657–673, 2000.

273. Gayowski T, Marino IR, Singh N, et al: Orthotopic

liver transplantation in high-risk patients: Risk

factors associated with mortality and infectious

morbidity. Transplantation 65:499–504, 1998.

274. Schechter S, Eisenstat TE, Oliver GC, et al: Compu-

terized tomographic scan-guided drainage of intra-

abdominal

abscesses:Preoperativeandpostoperative

modalities in colon and rectal surgery. Dis Colon

Rectum 37:984–988, 1994.

275. Patel R: Infections in recipients of kidney trans-

plants. Infect Dis Clin North Am 15:901–952, 2001.

276. Stratta RJ, Shokouh-Amiri MH, Egidi MF, et al: A

prospective comparison of simultaneous kidney-

pancreas transplantation with systemic-enteric

versus portal-enteric drainage. Ann Surg 233:740–

751, 2001.

277. Suthanthiran M, Morris RE, Strom TB: Immunosu-

ppressants: Cellular and molecular mechanisms of

action. Am J Kidney Dis 28:159–172, 1996.

278. Morris RE: Mechanisms of action of new immuno-

suppressive drugs. Kidney Int Suppl 53:S26–S38,

1996.

279. Allison AC: Immunosuppressive drugs: The first 50

years and a glance forward. Immunopharmacology

47:63–83, 2000.

280. Helderman JH, Bennett WM, Cibrik DM, et al:

Immunosuppression: Practice and trends. Am J

Transplant 3(Suppl 4): 41–52, 2003.

281. Kahan BD, Kramer WG: Median effect analysis of

efficacy versus adverse effects of immunosuppres-

sants. Clin Pharmacol Ther 70:74–81, 2001.

282. Euvrard S, Kanitakis J, Claudy A: Skin cancers after

organ transplantation. NEngl J Med 348:1681–1691,

2003.

283. Wacher VJ, Wu CY, Benet LZ: Overlapping substrate

specificities and tissue distribution of cytochrome

P450 3A and P-glycoprotein: Implications for drug

delivery and activity in cancer chemotherapy. Mol

Carcinog 13:129–134, 1995.

284. Schuetz EG, Beck WT, Schuetz JD: Modulators and

substrates of P-glycoprotein and cytochrome

P4503A coordinately up-regulate these proteins in

human colon carcinoma cells. Mol Pharmacol

49:311–318, 1996.

285. Lo A, Burckart GJ: P-glycoprotein and drug therapy

in organ transplantation. J Clin Pharmacol 39:995–

1005, 1999.

286. Backman JT, Kivisto KT, Olkkola KT, et al: The area

under the plasma concentration-time curve for oral

midazolam is 400-fold larger during treatment with

itraconazole than with rifampicin. Eur J Clin Phar-

macol 54:53–58, 1998.

287. Ahonen J, Olkkola KT, Takala A, et al: Interaction

between fluconazole and midazolam in intensive care

patients. Acta Anaesthesiol Scand 43:509–514, 1999.

288. Hoffman A, Habib G, Gilhar D, et al: Cyclosporin

increases the CNS sensitivity to the hypnotic effect

of phenobarbitone but not ethanol in rats. J Pharm

Pharmacol 46:760–764, 1994.

289. Thompson SJ, Koszdin K, Bernards CM: Opiate-

induced analgesia is increased and prolonged in

mice lacking P-glycoprotein. Anesthesiology

92:1392–1399, 2000.

Anestesia en el trasplante de órganos abdominales

1949

Sección IV

Anestesia por subespecialidades en el adulto